Response to: 'Comment on: 'EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update' by Gossec et al' by Wei et al

Affiliations

¹ Institut Pierre Louis d'Epidémiologie et de Santé Publique, INSERM, Sorbonne Universite, Paris, France laure.gossec@gmail.com.
² APHP, Rheumatology Department, Hopital Universitaire Pitie Salpetriere, Paris, France.
³ Rheumazentrum Ruhrgebiet, Ruhr-Universität Bochum, Herne, Germany.
⁴ Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.
⁵ Division of Rheumatology, Department of Medicine 3, and 2nd Department of Medicine, Medical University of Vienna, Hietzing Hospital, Vienna, Austria.
⁶ EULAR past Vice President representing People with Arthritis/Rheumatism in Europe (PARE), EULAR, Amsterdam, The Netherlands.
⁷ Medicine Faculty, Paris Descartes University, Paris, France.
⁸ Danish Hospital for Rheumatic Diseases, University Hospital of Southern Denmark, Sønderborg, Denmark.
⁹ Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.
¹⁰ Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
¹¹ Medical University of Vienna, Vienna, Austria.

Free article

Comment

Laure Gossec et al. Ann Rheum Dis. 2022 Aug.

Free article

. 2022 Aug;81(8):e139.

doi: 10.1136/annrheumdis-2020-218456. Epub 2020 Sep 1.

¹ Institut Pierre Louis d'Epidémiologie et de Santé Publique, INSERM, Sorbonne Universite, Paris, France laure.gossec@gmail.com.
² APHP, Rheumatology Department, Hopital Universitaire Pitie Salpetriere, Paris, France.
³ Rheumazentrum Ruhrgebiet, Ruhr-Universität Bochum, Herne, Germany.
⁴ Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.
⁵ Division of Rheumatology, Department of Medicine 3, and 2nd Department of Medicine, Medical University of Vienna, Hietzing Hospital, Vienna, Austria.
⁶ EULAR past Vice President representing People with Arthritis/Rheumatism in Europe (PARE), EULAR, Amsterdam, The Netherlands.
⁷ Medicine Faculty, Paris Descartes University, Paris, France.
⁸ Danish Hospital for Rheumatic Diseases, University Hospital of Southern Denmark, Sønderborg, Denmark.
⁹ Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.
¹⁰ Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
¹¹ Medical University of Vienna, Vienna, Austria.

No abstract available

Keywords: arthritis; biological therapy; epidemiology; psoriatic.

Conflict of interest statement

Competing interests: None declared.

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.
Gossec L, Baraliakos X, Kerschbaumer A, de Wit M, McInnes I, Dougados M, Primdahl J, McGonagle DG, Aletaha D, Balanescu A, Balint PV, Bertheussen H, Boehncke WH, Burmester GR, Canete JD, Damjanov NS, Kragstrup TW, Kvien TK, Landewé RBM, Lories RJU, Marzo-Ortega H, Poddubnyy D, Rodrigues Manica SA, Schett G, Veale DJ, Van den Bosch FE, van der Heijde D, Smolen JS. Gossec L, et al. Ann Rheum Dis. 2020 Jun;79(6):700-712. doi: 10.1136/annrheumdis-2020-217159. Ann Rheum Dis. 2020. PMID: 32434812 Free PMC article.
Comment on: 'EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update' by Gossec et al.
Wei CY, Lee YH, Wei JCC. Wei CY, et al. Ann Rheum Dis. 2022 Aug;81(8):e138. doi: 10.1136/annrheumdis-2020-218385. Epub 2020 Sep 1. Ann Rheum Dis. 2022. PMID: 32873556 No abstract available.